| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.085 | 0.03 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.03 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |